从6大细分领域着手促进医药健康产业发展

Core Viewpoint - Sichuan Province has introduced measures to promote the development of the pharmaceutical and health industry, focusing on six specific sectors: nuclear medicine, biomedicine, medical devices, sports, modern traditional Chinese medicine, and medical beauty [1][2] Group 1: Support for Innovation and Research - The measures support the establishment of national-level research platforms, including key laboratories for biotherapy and oral disease prevention, as well as major scientific infrastructure for translational medicine [1] - Emphasis is placed on collaboration between academic and research institutions and quality enterprises in the industry chain, particularly in areas like malignant tumors and emerging infectious diseases [1] - The initiative aims to develop innovative drug projects in fields such as cell therapy, gene therapy, synthetic biology, and brain science, along with a focus on creating a key research and development catalog for innovative drugs [1] Group 2: Financial Support and Incentives - The measures integrate resources to provide financial support for key industry projects, including a program that offers up to 40% of the total contract amount for project funding, with a maximum of 20 million yuan per project [2] - Specific subsidies are outlined for nuclear medicine projects, with a maximum subsidy of 20% of the project investment and a cap of 2 million yuan, while research projects can receive up to 30% of their R&D investment, capped at 1 million yuan [2] - Additional financial incentives include 40 million yuan annually for the top five cities in sports industry development, and up to 200,000 yuan for outdoor sports base construction projects [2] Group 3: Streamlined Processes - The measures establish a "key project service team" for pharmaceuticals and medical devices, ensuring that innovative drugs complete network review within 15 working days [2]